| 09:00-09:40 |
Symposium 01
KASL
Distinguished studies in hepatology: Reading the year — What truly mattered in 2025–2026?, and what comes next
|
Symposium 02
KSGE
Recent advances in third space endoscopy
|
Symposium 03
KASID
The first five years in IBD: Getting it right from the start
|
Symposium 04
KSNM
2026 GERD debates: Controversies and frontiers
|
Free Paper 01
Others 01
|
Basic/Translational Symposium
KSGC
Circulating & spatial biomarkers in GI cancer: From detection to treatment selection
|
Free Paper 03
PB 01
|
Symposium 05
KCHUGR
AI and microbiome research in gastric cancer
|
| 09:40-10:30 |
Free Paper 02
Others 02
|
Free Paper 04
PB 02
|
| 10:30-10:50 |
Coffee Break
|
| 10:50-11:30 |
Chung Yong Kim Memorial Lecture
KASL
(10:50-11:20)
|
Symposium 06
KSG
Modern big data research into real-world gastroenterology practice
|
Symposium 07
KASID
Update on IBD guidelines 2026: What’s new in KASID guidelines and beyond
|
Free Paper 05
FGID/Motility 01
|
Free Paper 07
Liver 01
|
Free Paper 09
Oncology 01
|
Symposium 08
KPBA
Regional phenotypes and contemporary management of chronic pancreatitis
|
Symposium 09
KCHUGR
New horizons in upper GI cancer management
|
| 11:30-12:20 |
General Meeting
KASL
(11:20-12:40)

|
Free Paper 06
FGID/Motility 02
|
Free Paper 08
Liver 02
|
Free Paper 10
Oncology 02
|
| 12:20-13:00 |
Luncheon Symposium
|
|
|
|
|
|
|
|
| 13:00-13:20 |
Coffee Break
|
| 13:20-14:00 |
Symposium 10
KASL
Contemporary approaches to chronic liver disease
|
Combined Symposium 01
KSG+KSSO
Obesity and gastrointestinal diseases: From inter-organ crosstalk to cancer and therapy
|
Symposium 11
KASID
Personalizing comprehensive care in IBD
|
Symposium 12
KSGE
Upper GI leaks & fistulas: Algorithm-based treatment and advanced endoscopic therapies
|
Free Paper 11
Liver 03
|
Symposium 13
KSGC
Treatment beyond progression: New concepts in refractory GI cancers
|
Free Paper 13
PB 03
|
Symposium 14
KCHUGR
Clinical updates and decision making for Helicobacter pylori eradication
|
| 14:00-14:50 |
Free Paper 12
Liver 04
|
Free Paper 14
PB 04
|
| 14:50-15:10 |
Coffee Break
|
| 15:10-15:50 |
Symposium 15
KASL
First-line (1L) systemic therapy for HCC: Beyond the choice—strategy, sequencing, and synergy
|
Combined Symposium 02
KCHUGR+KSNM
Managing uncertainty in the upper GI tract through gray zones and near-miss cases
|
Multidisciplinary Symposium 01
KSGC
Redefining resectability in pancreatic cancer
|
|
Symposium 16
Editor Session
TBD
|
Free Paper 15
Oncology 03
|
Symposium 17
KPBA
Optimizing surgical outcomes in perihilar cholangiocarcinoma
|
|
| 15:50-16:40 |
|